AHMED MAHIUDDIN enters Y-MABS THERAPEUTICS, INC. with 260K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/9/2020ACC: 0001104659-20-002746
Officer· Sr. VP and CSO
Since Jan 2020
260K
Baseline shares
100% direct
260K
Direct ownership
1 position
60K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned260K
Total
260K direct260K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 260K | Direct |
| Total | 260K | 260K direct |
Derivative Holdings3
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
20K
Shares owned
N/A
Exercise price
11.16
Expiration
—
Exercise window
—
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
20K
Shares owned
N/A
Exercise price
21.45
Expiration
—
Exercise window
—
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
20K
Shares owned
N/A
Exercise price
33.74
Expiration
—
Exercise window
—
Total
Underlying
60K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock | 11.16 | — | — | 20K | N/A |
| Employee Stock Option (right to buy) Direct | Common Stock | 21.45 | — | — | 20K | N/A |
| Employee Stock Option (right to buy) Direct | Common Stock | 33.74 | — | — | 20K | N/A |
| Total | 60K | 0.00 | ||||